{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:42:37Z","timestamp":1792460557161,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pre-eclampsia is a major cause of perinatal morbidity and mortality worldwide. Late-onset pre-eclampsia (LOP), which results in delivery \u226534\u2009weeks gestation, is the most common type. However, there is a lack of knowledge in its prediction and prevention. Improving our understanding in this area will allow us to have better surveillance of high-risk patients and thus improve clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic review was performed using a search of articles on PubMed. The search terms were ((late-onset) AND (pre-eclampsia)) AND ((risk factor) OR (risk) OR (prediction) OR (management) OR (prevention)). Primary literature published between 1 January 2013 and 31 December 2023 was included. Human studies assessing the prediction or prevention of late-onset pre-eclampsia were eligible for inclusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixteen articles were included in the final review. The key risk factors identified were Body Mass Index (BMI), chronic hypertension, elevated mean arterial pressures (MAPs), nulliparity, and maternal age. No clinically useful predictive model for LOP was found. Initiating low dose aspirin before 17\u2009weeks gestation in high-risk patients may help reduce the risk of LOP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>While aspirin is a promising preventor of LOP, preventative measures for women not deemed to be at high-risk or measures that can be implemented at a later gestation are required. Biomarkers for LOP need to be identified, and examining large cohorts during the second or third trimester may yield useful results, as this is when the pathogenesis is hypothesized to occur. Biomarkers that identify high-risk LOP patients may also help find preventative measures.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1459289","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T09:18:18Z","timestamp":1732180698000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Prediction and prevention of late-onset pre-eclampsia: a systematic review"],"prefix":"10.3389","volume":"11","author":[{"given":"Anna","family":"Baylis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Menkhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"Von Dadelszen","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"E237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia","volume":"135","author":"Espinoza","year":"2020","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/HYPERTENSIONAHA.108.117358","article-title":"Early and late preeclampsia","volume":"52","author":"Valensise","year":"2008","journal-title":"Hypertension"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","article-title":"Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction","volume":"62","author":"Lyall","year":"2013","journal-title":"Hypertension"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4274\/tjod.galenos.2019.93708","article-title":"First trimester complete blood cell indices in early and late onset preeclampsia","volume":"16","author":"\u00d6rg\u00fcl","year":"2019","journal-title":"Turk J Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.110.150078","article-title":"Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort","volume":"56","author":"Mongraw-Chaffin","year":"2010","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0223888","DOI":"10.1371\/journal.pone.0223888","article-title":"Increased BMI has a linear association with late-onset preeclampsia: a population-based study","volume":"14","author":"Robillard","year":"2019","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/00365513.2022.2155991","article-title":"First trimester serum apolipoproteins in the prediction of late-onset preeclampsia","volume":"83","author":"Bendix","year":"2023","journal-title":"Scand J Clin Lab Invest"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ijgo.12531","article-title":"Comparison of materno-fetal predictors and short-term outcomes between early and late onset pre-eclampsia in the low-income setting of Douala, Cameroon","volume":"142","author":"Nguefack","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jri.2017.08.005","article-title":"Comparison of risk factors and perinatal outcomes in early onset and late onset preeclampsia: a cohort based study in Reunion Island","volume":"123","author":"Iacobelli","year":"2017","journal-title":"J Reprod Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/1099800419833782","article-title":"Maternal ABO blood type and factors associated with preeclampsia subtype","volume":"21","author":"Burgess","year":"2019","journal-title":"Biol Res Nurs"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-018-1908-9","article-title":"Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models","volume":"18","author":"Murtoniemi","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.preghy.2020.07.008","article-title":"Circulating pregnancy hormone relaxin as a first trimester biomarker for preeclampsia","volume":"22","author":"Uiterweer","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.preghy.2021.01.002","article-title":"Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota","volume":"23","author":"Altemani","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejogrb.2016.03.011","article-title":"Comparison of plasma fetuin a levels in patients with early-onset pre-eclampsia vs late-onset pre-eclampsia","volume":"200","author":"Sanhal","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/aji.12541","article-title":"Expression of the complement system's activation factors in plasma of patients with early\/late-onset severe pre-eclampsia","volume":"76","author":"He","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"126.e1","DOI":"10.1016\/j.ajog.2017.10.024","article-title":"First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume","volume":"218","author":"Sonek","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/uog.13310","article-title":"Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia","volume":"44","author":"Verlohren","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e021376","DOI":"10.1161\/JAHA.120.021376","article-title":"Decision threshold for Kryptor sFlt-1\/PlGF ratio in women with suspected preeclampsia: retrospective study in a routine clinical setting","volume":"10","author":"Andersen","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1002\/jcb.26640","article-title":"Impact of IL-22 and IL-22 receptor alpha 1 polymorphisms on preeclampsia risk in Chinese Han women","volume":"119","author":"Niu","year":"2018","journal-title":"J Cell Biochem"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/jp.2014.214","article-title":"Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU high-risk aspirin study","volume":"35","author":"Moore","year":"2015","journal-title":"J Perinatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1161\/HYPERTENSIONAHA.119.14107","article-title":"Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study","volume":"75","author":"Shanmugalingam","year":"2020","journal-title":"Hypertension"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","article-title":"Inflammation and pre-eclampsia","volume":"11","author":"Borzychowski","year":"2006","journal-title":"Semin Neonatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin Immunopathol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.105.588723","article-title":"Association between human fetuin-a and the metabolic syndrome: data from the heart and soul study","volume":"113","author":"Ix","year":"2006","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e0229776","DOI":"10.1371\/journal.pone.0229776","article-title":"Fetuin-a in metabolic syndrome: a systematic review and meta-analysis","volume":"15","author":"Pan","year":"2020","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00592-017-1068-9","article-title":"Fetuin-a levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"55","author":"Guo","year":"2018","journal-title":"Acta Diabetol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"\u03b12-Heremans-Schmid glycoprotein\/ Fetuin-a is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e1003679","DOI":"10.1371\/journal.pmed.1003679","article-title":"Obesity and risk of female reproductive conditions: a Mendelian randomisation study","volume":"19","author":"Venkatesh","year":"2022","journal-title":"PLoS Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr Diab Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1001\/jama.2022.3189","article-title":"Risk of adverse pregnancy outcomes among pregnant individuals with gestational diabetes by race and ethnicity in the United States, 2014-2020","volume":"327","author":"Venkatesh","year":"2022","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e00285","DOI":"10.1002\/edm2.285","article-title":"Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South Asia: a systematic review","volume":"4","author":"Mistry","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.2337\/db22-0168","article-title":"Butyrate-producing bacteria and insulin homeostasis: the microbiome and insulin longitudinal evaluation study (MILES)","volume":"71","author":"Cui","year":"2022","journal-title":"Diabetes"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e2244912","DOI":"10.1001\/jamanetworkopen.2022.44912","article-title":"Therapeutic effects of butyrate on pediatric obesity: a randomized clinical trial","volume":"5","author":"Coppola","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"101203","DOI":"10.1016\/j.ajogmf.2023.101203","article-title":"Expert review: preeclampsia type I and type II","volume":"5","author":"Yagel","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"103463","DOI":"10.1016\/j.jri.2021.103463","article-title":"Association of IL1R1 gene (SNP rs2071374) with the risk of preeclampsia","volume":"149","author":"Sivaraj","year":"2022","journal-title":"J Reprod Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2019.04.049","article-title":"Novel association of SNP rs479200 in EGLN1 gene with predisposition to preeclampsia","volume":"705","author":"KS","year":"2019","journal-title":"Gene"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cca.2018.05.013","article-title":"A tag SNP in syncytin-2 3-UTR significantly correlates with the risk of severe preeclampsia","volume":"483","author":"Hua","year":"2018","journal-title":"Clin Chim Acta"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bpobgyn.2011.02.007","article-title":"The genetics of pre-eclampsia and other hypertensive disorders of pregnancy","volume":"25","author":"Williams","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/10641955.2020.1777298","article-title":"Relationship between ABO blood groups and preeclampsia","volume":"39","author":"Mahasub","year":"2020","journal-title":"Hypertens Pregnancy"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1459289\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T09:18:22Z","timestamp":1732180702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1459289\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":57,"alternative-id":["10.3389\/fmed.2024.1459289"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1459289","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"article-number":"1459289"}}